Chris Keh - Concepedia

Author

Chris Keh

University of California, San Francisco

Also Known As

Chris E Keh, Chris E. Keh, Chris Keh, Shereen Katrak

Publications

409

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco Vanderbilt University Medical Center University of North Texas Maricopa County Department of Public Health California Department of Public Health

About

Chris Keh is an author at University of California, San Francisco specializing in medicine, tuberculosis, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	134
2	Public Health	1	1	29
3	Cell Biology	1	1	17
4	Counseling	1	1	29
5	Health Policy	1	1	29

Chris Keh

Publications

297

Citations

H-Index

Page 1

	Year	Citations
Two Rapidly Growing Mycobacterial Species Isolated from a Brain Abscess: First Whole-Genome Sequences of Mycobacterium immunogenum and Mycobacterium llatzerense Alexander L. Greninger, Charles Langelier, Gail Cunningham, Journal of Clinical Microbiology M. LlatzerenseMedical MicrobiologyMycobacterium LlatzerenseMicrobial SystematicsPathogenic Microbiology	2015	50
Expansion of CD8+ T cells lacking Sema4D/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity Emily M. Eriksson, Jeffrey M. Milush, Emily Ho, Blood	2011	45
Cost of Tuberculosis Therapy Directly Observed on Video for Health Departments and Patients in New York City; San Francisco, California; and Rhode Island (2017–2018) Garrett R. Beeler Asay, Chee Kin Lam, Brock Stewart, American Journal of Public Health	2020	32
Evaluation of the Latent Tuberculosis Care Cascade Among Public Health Clinics in the United States Samuel B. Holzman, Allison Perry, Paul Saleeb, Clinical Infectious Diseases	2022	30
A Resident-Led Quality Improvement Initiative to Improve Obesity Screening Neda Laiteerapong, Chris Keh, Keith Naylor, American Journal of Medical Quality ObesityCounselingLifestyle ModificationHealth PolicyBody Mass Index	2011	29
Possible Neuropsychiatric Reaction to High‐Dose Oseltamivir during Acute 2009 H1N1 Influenza A Infection Kenta Nakamura, Brian S. Schwartz, Niklas Lindegårdh, Clinical Infectious Diseases High‐dose OseltamivirHigh-dose OseltamivirPsychiatryNeurovirologyPatient Safety	2010	21
Comparison of Tuberculin Skin Testing and Interferon-γ Release Assays in Predicting Tuberculosis Disease Tracy Ayers, Andrew Hill, Julia Raykin, JAMA Network Open	2024	18
Differential Expression of CD96 Surface Molecule Represents CD8+ T Cells with Dissimilar Effector Function during HIV-1 Infection Emily M. Eriksson, Chris Keh, Steven G. Deeks, PLoS ONE ImmunologyImmune RegulationCd4 T Cell ResponsesImmunotherapyHuman Retrovirus	2012	17
Second Nationwide Tuberculosis Outbreak Caused by Bone Allografts Containing Live Cells — United States, 2023 Jonathan M. Wortham, Maryam B. Haddad, Rebekah J. Stewart, MMWR Morbidity and Mortality Weekly Report Translational MedicineMolecular Diagnostic TechniquesPulmonary TuberculosisTuberculosis PreventionClinical Epidemiology	2024	17
Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patients Chris Keh, Jean Shen, Barbara Hahn, AIDS	2006	14

Page 1